Similarly, Jia et al. showed that WTAP, a key component of the m6A methyltransferase complex, was methylated by Protein Arginine Methyltransferase 1 (PRMT1), and the combination of a PRMT1 inhibitor and BTZ synergistically inhibited MM progression [64]. This evidence concerns the gene PRMT1 and Miyoshi myopathy.